Navigation Links
Johnson & Johnson Announces Definitive Agreement to Acquire Cougar Biotechnology, Inc.
Date:5/21/2009

patients with metastatic, castration-resistant prostate cancer who have progressed after docetaxel-based chemotherapy has failed. The second Phase III trial is studying abiraterone acetate in patients with metastatic, castration-resistant prostate cancer who have yet to receive chemotherapy. One in six men will be diagnosed with prostate cancer in his lifetime, and the disease accounts for 10 percent of cancer-related deaths in the United States.

"The acquisition of Cougar Biotechnology with its talented team will strengthen our growing capabilities toward a leadership position in the global oncology market," said William N. Hait, M.D., Ph.D., Global Therapeutic Head, Oncology, Ortho Biotech Oncology Research & Development. "We are developing new treatments that we anticipate will change the course of cancer treatment by targeting the tumor and its microenvironment and thereby will provide a meaningful difference in the lives of millions of patients worldwide."

Alan H. Auerbach, Chief Executive Officer, President and Founder of Cougar Biotechnology, said, "Since the founding of Cougar approximately six years ago, our employees have been relentlessly dedicated to the development of innovative oncology drugs and the creation of shareholder value. We believe that this transaction strongly positions abiraterone acetate for future success with a leading healthcare company that has the expertise, resources, dedication and motivation to deliver it to the cancer patients who need it."

Upon closing, the transaction is expected to have a dilutive impact to Johnson & Johnson's 2009 earnings per share of approximately $.02 to $.03. The transaction is expected to close in the third quarter of 2009.

About Johnson & Johnson

Caring for the world, one person at a time ... inspires and unites the people of Johnson & Johnson. We embrace research and science -- bringing innova
'/>"/>

SOURCE Johnson & Johnson
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Simbionix and Johnson & Johnson LLC Announce a Distribution Agreement for Russia and the CIS Countries
2. Burnham Announces Assay Development and License Agreement with Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
3. Johnson & Johnson Completes Acquisition of Omrix Biopharmaceuticals, Inc.
4. Johnson & Johnson Announces Definitive Agreement to Acquire Omrix
5. Cynvec LLC(SM) Appoints Former Johnson & Johnson Executive Frank D. Stonebanks as President and Chief Executive Officer
6. Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Submits New Drug Application to FDA for Carisbamate
7. Sustainable Oils Names Scott Johnson as General Manager, Expands Management Team for Camelina Research and Production
8. Johnson & Johnson Honors 2008 Recipients of The Dr. Paul Janssen Award for Biomedical Research
9. Migenix averts proxy contest; reaches agreement with DJohnson holdings
10. Craig Johnson Joins Ardea Biosciences Board of Directors
11. Ortho Biotech Oncology Research & Development Unites Johnson & Johnson Biopharmaceutical Oncology R&D Assets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... 31, 2015  University of Illinois, ... deliver the plenary session address on Monday, May 18 ... (IMS) , kicking off a week of more than ... intersection of RF and microwave technologies with health. ... Sensors and Circuits for the Skin," will focus on ...
(Date:3/30/2015)... With recent advancements in residential solar power ... companies are getting into the Solar Energy wave. ... renewable energy production, many homeowners are looking to residential ... a new solar distribution company in California which has ... homeowners to enjoy the benefits of solar energy without ...
(Date:3/30/2015)... 30, 2015  New Jersey Health Foundation, a not-for-profit ... state of New Jersey , has ... funding, announced James M. Golubieski , president. ... Grants program, an additional $500,000 will be available for ... stage research projects that demonstrate exciting potential and may ...
(Date:3/30/2015)... BETHESDA, Md. , March 30, 2015 /PRNewswire/ ... development company committed to the fostering and monetization ... Spherix v. VTech,  Case No. 3:13-cv-03494-M and  Spherix ... the United States District Court for the Northern ... an update regarding Spherix v. Verizon, ...
Breaking Biology Technology:Health and Engineering Converge at the 2015 International Microwave Symposium 2Health and Engineering Converge at the 2015 International Microwave Symposium 3Solara Power Announces Residential Solar Power with No Up-Front Fees 2New Jersey Health Foundation Announces An Additional $1 Million To Fund Innovation and Research Grants in New Jersey 2Spherix Provides Update on Litigation vs. VTech, Uniden and Verizon 2Spherix Provides Update on Litigation vs. VTech, Uniden and Verizon 3
... 7 BioEnergy International, LLC,(BioEnergy), a privately-held, ... and biofuels, announces the,addition of Norman R. ... December,2008. Mr. Augustine has a record of ... of industry and government culminating in his ...
... Vaccine Has Potential to Save Millions of Lives, ... Inc.,(IBT), a biotechnology company focused on development of ... have been awarded a multiyear contract for advanced ... Marburg viruses from the National,Institute of Allergy and ...
... Imaging,Diagnostic Systems, Inc., (OTC Bulletin Board: IMDS) a ... today that its distributor,The Oyamo group has place ... (CTLM(R)) for Jerusalem, Israel., (Logo: http://www.newscom.com/cgi-bin/prnh/20040412/IMDSLOGO ... import license from the Israel Ministry of,Health which ...
Cached Biology Technology:BioEnergy International, LLC Announces Norman R. Augustine to Join Advisory Board 2BioEnergy International, LLC Announces Norman R. Augustine to Join Advisory Board 3Integrated BioTherapeutics Awarded NIAID Contract For Up to $65 Million for Development of a Vaccine against Ebola and Marburg Viruses 2Integrated BioTherapeutics Awarded NIAID Contract For Up to $65 Million for Development of a Vaccine against Ebola and Marburg Viruses 3Imaging Diagnostic Systems Receives its First Order for its CT Laser Mammography System for Israel 2
(Date:3/17/2015)... 17, 2015  MecklerMedia Corporation (OTCQX: MECK) announced ... service robots ever held in New ... May 11-13, 2015 at the Javits Convention Center. ... event include: Acorn Product Development; Axis NJ; c-Link ... Robotics; Littler; NewBotic Corporation; Neya Systems LLC; Reliabotics; ...
(Date:3/12/2015)... -- Beta Systems today announced Fast ... (IAM) solution for a fixed price and with ... IAM package, customers benefit from the 30 years, ... implementations across different industries. The new fixed-price IAM ... necessary services and consulting. It spans the implementation ...
(Date:3/10/2015)... 2015  Continuing its 167-year history of offering the ... The Eye Scanning Password Authenticator , a device ... secure websites or sensitive data. Employing the ... borders, the device has a small camera that scans ... iris, converting them into an encrypted ID that cannot ...
Breaking Biology News(10 mins):MecklerMedia's RoboUniverse New York Announces Sponsors and Exhibitors, May 11-13, 2015 2Beta Systems Fast Forward IAM Available Now: a Standardized IAM Package at a Fixed Price 2Hammacher Schlemmer Introduces The Eye Scanning Password Authenticator 2
... Italy , May 10, 2010 Health ... security guidelines for controlled substances, including,tamper-evident syringe caps, biometric identification, ... , , , ... "In addition to being the only ...
... A new commentary on the nature of pathogens is raising ... on evolution plays in the understanding of emerging disease. Ecological ... a population shifts onto a novel host, is one of ... in plants, argue the authors of a new paper published ...
... URBANA A recent research study has shown ... amounts of food due to resource constraints, can lead ... woman,s pregnancy. "Prior studies have shown that ... to experience health complications," said Craig Gundersen, a University ...
Cached Biology News:Health Robotics' i.v.STATION Certified as the Only Robot to Comply with Security Guidelines for Controlled Substances 2Health Robotics' i.v.STATION Certified as the Only Robot to Comply with Security Guidelines for Controlled Substances 3Health Robotics' i.v.STATION Certified as the Only Robot to Comply with Security Guidelines for Controlled Substances 4Emergence of fungal plant diseases linked to ecological speciation 2Food insecurity increases risk of weight gain and complications during pregnancy 2
... Mouse P815 cells were cultured in DMEM and ... In order to keep the antigens in their ... The cells are arrayed on a 12-well (5 ... specifically treated to enhance cellular attachment and to ...
...
Screening assay to detect the Listeria monocytogenes in food samples by,DNA amplification and molecular hybridization on a microtiter plate....
Multi-enzyme complex containing a wide range of carbohydrases, including arabanase, cellulase,b-glucanase, hemi-cellulase and xylanase Patent/trademark/license (electronic): A product of Novozyme Cor...
Biology Products: